Skip to main content

UBS Group AG

Position in RNXT — RenovoRx, Inc.

CIK 1610520 ZURICH, V8

Position in RNXT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,403
+$17,032 QoQ
Shares Held
20,820
+523.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 28 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNXT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. RNXT ranks #424 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RNXT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,403 20,820
2026-03-31 $3,371 3,338
2025-12-31 $1,913 2,279
2025-09-30 $852 671
2025-06-30 $39,460 30,009
2025-03-31 $66,064 66,732
2024-12-31 $15,822 12,266
2024-09-30 $2,370 2,236
2024-06-30 $1,474 1,305
2023-03-31 $8,817 2,530
2022-09-30 $2,537 1,256
2022-06-30 $12,309 6,217
2021-12-31 $21,838 4,512